By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Madison Williams and Co., has started coverage of the life sciences tools industry, providing initial analysis on Bruker, Caliper Life Sciences, WaferGen BioSystems, and Waters.

Overall, analyst Greg Bolan said in a report that he is "bullish toward the secular theme of growing use of life sciences technologies and we feel the very recent contraction in [life science] valuations has created significant buying opportunities for several stocks."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.